Pharmaceutical manufacturers are unknowingly leaking as much as 6% of their revenue due ineffective systems used to manage complex pricing, rebating and regulatory processes. That’s $60 million in revenue leakage for every billion dollars under management.
Get clarity in 2020 and beyond by learning actionable strategies to eliminate revenue leakage and compliance risk, while enabling profitable revenue growth in all channels.
Get Your Free Revenue Execution Assessment
The supply chain for drugs, biologics and medical devices is very complex and without proper management, pharma companies are losing as much as 6% of revenue in overpayments, fees, and inaccurate pricing. The price waterfall shows the elements that affect profitability between base to list price through a manufacturer’s pocket margin. Understanding the full picture is key to finding ways to stop revenue leakage and grow your top line.
The global pharmaceutical industry is facing complex and challenging market dynamics t ...
Join IDC and Model N to learn about evolving trends, market developments, and gain ins ...
Despite recent advances in technology, particularly around data and analytics, 95% of companies are leaking revenue, and 82% of executives...
By Erica Bartlett, Product Manager Value-based agreements (VBAs), sometimes called outcomes-based agreements, are on the rise. According to Aetna, it is estimated...
Download the analyst connection to get IDC’s SaaS insights to help you navigate your r ...
Model N’s Validata solution utilizes cloud-based technology to offer automated script- ...
By Kelly Walter, Vice President of Sales, Life Sciences, Model N Are you paying just what you owe on government...
